Shows / DDReg Knowledge Capsule

DDReg Knowledge Capsule
🎧 DDReg Knowledge Capsule Welcome to the DDReg Knowledge Capsule — your go-to podcast for concise, insightful conversations on the latest trends, innovations, and challenges in the life sciences industry. Brought to you by the experts at DDReg, this series distills complex regulatory affairs, pharmacovigilance, market access, and clinical development topics into easy-to-understand episodes. Subscribe now and empower your pharma journey, one capsule at a time.
Episodes
DDReg Knowledge CapsuleDrug Registration in Spain: AEMPS Process & 2026 Timeline
What does it take to successfully register a medicine in Spain in 2026? In this episode, we dive into the Agencia Española de Medicamentos y Productos…
DDReg Knowledge CapsuleWinning AIFA Drug Reimbursement in Italy: Regulatory & HTA Roadmap
Navigating pharmaceutical launch in Italy requires far more than securing European or national marketing authorization. In this episode of the DDReg Knowledge…
DDReg Knowledge CapsuleNavigating EMA’s Voluntary Data Submission Pilot for NAMs
Welcome to the DDReg Knowledge Capsule! In this episode, we unpack the EMA’s Voluntary Data Submission pilot for New Approach Methodologies (NAMs). Learn how…
DDReg Knowledge CapsuleNavigate German Nutraceutical & Novel Food Compliance
When does a nutraceutical ingredient become a Novel Food regulatory concern? 🌿 Explore Germany’s nutraceutical market, EU Novel Food regulations, ingredient…
DDReg Knowledge CapsuleJapan & Malaysia: Faster Clinical Trial Approvals? 🌏
Can regulatory reliance accelerate clinical trial approvals in Japan and Malaysia? Discover how the new pilot could streamline regulatory reviews, reduce…
DDReg Knowledge CapsuleGlobal-to-Local Pharmacovigilance: Bridging Safety Gaps
How can Marketing Authorization Holders (MAHs) prevent gaps between global and local safety teams? 🌍 Discover key strategies for stronger pharmacovigilance…
DDReg Knowledge CapsuleRealities of EAEU Pharmaceutical Registration
Welcome to DDReg Knowledge Capsule! In this episode, we unpack the complexities of pharmaceutical registration across the Eurasian Economic Union…
DDReg Knowledge CapsuleMedical Device Registration in Kenya: Beyond Approval
Entering Kenya’s medical device market? 🌍 Discover the key regulatory requirements foreign manufacturers need to know beyond product registration, including…
DDReg Knowledge CapsuleDietary Supplement Registration in Brazil vs. Mexico ANVISA and COFEPRIS Market Entry Pathways
"Welcome to the DDReg Knowledge Capsule" — This episode explores the contrasting regulatory pathways for entering the dietary supplement markets in Brazil and…
DDReg Knowledge CapsuleStrategic Regulatory Intelligence: Turning Regulatory Signals into Product Decisions
DDReg Knowledge Capsule, discover how pharmaceutical leaders move beyond passive regulatory monitoring to build a decision-oriented strategy that directly…
DDReg Knowledge CapsuleSouth Korea KDMF Requirements for Imported APIs
Welcome to the DDReg Knowledge Capsule" — This episode provides a practical overview of South Korea's Korea Drug Master File (KDMF) registration framework…
DDReg Knowledge CapsuleRegulatory Data Quality: The Hidden Risk Behind Submission & Compliance
Regulatory success depends on more than an accurate dossier. In today’s data-driven pharmaceutical environment, inconsistent product information across…
DDReg Knowledge CapsulePharmacovigilance Launch Readiness For Marketing Authorization Holders
Welcome back to the DDReg Knowledge Capsule! In this episode, we explore how Marketing Authorization Holders (MAHs) build and maintain compliant…
DDReg Knowledge CapsuleThe Strategic Role of Regulatory Affairs in Pharma Industry
In this edition of the DDReg Knowledge Capsule, we explore how Regulatory Affairs guides medicinal products from early research through market authorization…
DDReg Knowledge CapsuleGlobal Biosimilar Pathways 2026 : US, EU, UK & Asia
Welcome to the DDReg Knowledge Capsule! In this episode, we unpack the rapidly changing global regulatory landscape for biosimilar development across key…
DDReg Knowledge CapsuleRegistering Biosimilar Drugs with Health Canada
Welcome to DDReg Knowledge Capsule! In this episode, we explore Health Canada's regulatory framework for registering biosimilar biologic drugs. We break down…
DDReg Knowledge CapsuleGlobal Regulatory Operating Model For Pharma Leaders
This episode explores how pharmaceutical organisations can effectively structure regulatory roles across global, regional, and local markets. Based on the…
DDReg Knowledge CapsuleMastering Global CMC Variations & Life Cycle Management
Welcome to DDReg Knowledge Capsule! In this episode, we dive into the complex world of global post-approval change management in the pharmaceutical…
DDReg Knowledge CapsuleMalaysia NPRA 2026: Fast Route for Biosimilar Registration
Welcome to the DDREG Knowledge Capsule. In this episode, we unpack the National Pharmaceutical Regulatory Agency's (NPRA) landmark 2026 reliance pilot pathway…
DDReg Knowledge CapsuleMandatory EUDAMED Compliance for German Medical Devices 2026
Welcome to this episode of the DDReg Knowledge Capsule. In this session, we break down Germany's critical regulatory transition from the national DMIDS…
DDReg Knowledge CapsuleIndia's Pharma Shift from Generics to Innovation
India is evolving from "the pharmacy of the world" to a powerhouse of pharmaceutical innovation, focusing on biosimilars, complex generics, and advanced…
DDReg Knowledge CapsuleWhy Gene Therapy Manufacturing Fails FDA
Why do even the most revolutionary gene therapies with promising clinical results face critical roadblocks on their path to commercial approval? In this…
DDReg Knowledge CapsuleNavigating the UAE's MOHAP to EDE Transition
Welcome to the DDReg Knowledge Capsule. In this episode, we unpack the historic shift in the UAE’s healthcare regulatory framework as the Emirates Drug…
DDReg Knowledge CapsuleJordan Joins PICS Pharmaceutical Inspection Scheme
Welcome to the DDReg Knowledge Capsule! In this episode, we explore the major regulatory milestone of 1 January 2026, when the Jordan Food and Drug…
DDReg Knowledge CapsuleAI in Regulatory Affairs: What It Can and Can’t Do in 2026
Welcome to the DDReg Knowledge Capsule. In this episode, we cut through the industry hype to examine exactly what AI can and cannot do in 2026. Learn why AI…
DDReg Knowledge CapsuleNAFDAC Drug Registration: Nigeria Market Access Guide (2026)
This Podcast about Nigeria has emerged as one of Africa’s most dynamic pharmaceutical markets, but for global manufacturers, the path to entry is defined by…
DDReg Knowledge CapsuleThe RaaS Revolution in Pharma 2026
In this episode, we explore why pharmaceutical companies are moving away from traditional internal departments and adopting Regulatory-as-a-Service (RaaS). We…
DDReg Knowledge CapsuleWinning Thailand FDA Priority Drug Approvals
Welcome to the DDReg Knowledge Capsule. In this episode, we demystify the Thailand FDA Priority Review, a process that functions more as a controlled…
DDReg Knowledge CapsuleEgypt EDA Drug Approval and Registration Guide
This episode explores why Egypt is a top priority for regional expansion, boasting a pharmaceutical sector valued at approximately USD 5.9 billion.We dive into…
DDReg Knowledge CapsuleNavigating TGA Australia Drug Registration and Compliance
This episode provides a comprehensive guide to the Therapeutic Goods Act 1989, exploring the various pathways for getting prescription medicines onto the…
DDReg Knowledge CapsuleGlobal Orphan Drug Designations: Building a Cross-Market Strategy
In this episode of the DDReg Knowledge Capsule, we explore the strategic importance of building a comprehensive, multi-market regulatory approach for rare…
DDReg Knowledge CapsuleSri Lanka’s 2026 Medical Device Regulatory Registration
In this episode, we explore the significant transformation of the medical device landscape in Sri Lanka under the mandate of the NMRA. We break down the…
DDReg Knowledge CapsuleSouth Korea MFDS Drug Registration: 2026 Updates and Approval Guide
This episode explores the significant 2026 updates to the Ministry of Food and Drug Safety (MFDS) drug registration process in South Korea. We dive into the…
DDReg Knowledge Capsule2026 SFDA Roadmap: Mastering Pharmaceutical Registration in Saudi Arabia
In this episode of the DDReg Knowledge Capsule, we explore the regulatory complexities of entering the Middle East’s largest pharmaceutical market, currently…
DDReg Knowledge CapsuleHow To Winning the ANVISA Drug Registration Race
This podcast, Episode [32], introduced with the "DDReg Knowledge capsule" greeting, provides a deep dive into the complexities of pharmaceutical registration…
DDReg Knowledge CapsuleThe Blueprint for Effective Pharmacovigilance SOPs
Welcome to this episode of the DDReg Knowledge Capsule, Episode [31] where we explore the critical role of Standard Operating Procedures (SOPs) as the…
DDReg Knowledge CapsuleIndonesia's Pharma Market: BPOM Drug Registration Decoded
📢 DDReg Knowledge Capsule – Episode [30]This podcast provides an in-depth analysis of Indonesia's regulatory landscape, the largest pharmaceutical market in…
DDReg Knowledge CapsuleThe WHO Global Strategy on Digital Health 2027 Framework
📢 DDReg Knowledge Capsule – Episode [29] The shift in global healthcare as digital tools move from experimental pilots to core national infrastructure. It…
DDReg Knowledge CapsuleRegulatory Impact of Manufacturing Site Transfers
📢 DDReg Knowledge Capsule – Episode [28] This podcast covers the analysis of the regulatory complexities involved when relocating production facilities for…
DDReg Knowledge CapsulePost-Market Clinical Follow-Up: Regulatory Obligations and Documentation Strategies
📢 DDReg Knowledge Capsule – Episode [27] This podcast covers Post-Market Clinical Follow-up (PMCF) under the European Union’s Medical Device Regulation (MDR)…
DDReg Knowledge CapsuleEthnic Sensitivity Factors in Global Drug Development
📢 DDReg Knowledge Capsule – Episode [26] This podcast cover about how ethnic sensitivity influences the creation and approval of pharmaceuticals on a global…
DDReg Knowledge CapsuleMandating Bridging Studies Under ICH E5 Regulatory Criteria
📢 DDReg Knowledge Capsule – Episode [25] This podcast cover about ICH E5 guidelines mandate bridging studies when foreign clinical data cannot reliably predict…
DDReg Knowledge CapsuleCultural Nuances in Global Adverse Event Reporting
📢 DDReg Knowledge Capsule – Episode [24] How cultural influences create significant discrepancies in adverse event reporting and patient-reported outcomes…
DDReg Knowledge CapsuleScaling Quality Compliance and Audits Across Global Networks
📢 DDReg Knowledge Capsule – Episode [23]importance of maintaining rigorous oversight of external vendors within the international pharmaceutical and medical…
DDReg Knowledge Capsule🧬 Clinical Trial Design Strategies for Advanced Therapies
📢 DDReg Knowledge Capsule – Episode [22]Designing clinical trials specifically for advanced medicinal products such as gene and cell therapies. Because these…
DDReg Knowledge CapsuleAdvanced FMEA in Medical Device Lifecycle Management
📢 DDReg Knowledge Capsule – Episode [22] Failure Mode and Effects Analysis (FMEA) as a dynamic tool for managing medical device risks throughout their entire…
DDReg Knowledge Capsule10 Rules For 2026 Life Sciences Approvals
📢 DDReg Knowledge Capsule – Episode [21] Integration of Artificial Intelligence and the establishment of digital trust. It asserts that the pervasive use of AI…
DDReg Knowledge CapsuleFDA 510(k) Submission Process Guide for 2026
📢 DDReg Knowledge Capsule – Episode [20] Integration of Artificial Intelligence and the establishment of digital trust. It asserts that the pervasive use of AI…
DDReg Knowledge CapsuleAI Auditability: The Foundation of Digital Trust in Pharma
📢 DDReg Knowledge Capsule – Episode [20]Integration of Artificial Intelligence and the establishment of digital trust. It asserts that the pervasive use of AI…
DDReg Knowledge CapsuleThe Regulatory Nexus: Borderline Product Classification
📢 DDReg Knowledge Capsule – Episode [19] These products, which often exhibit characteristics overlapping categories like medicines, medical devices, and food…
DDReg Knowledge CapsuleHong Kong's Mandatory Medical Device Registration Transition
📢 DDReg Knowledge Capsule – Episode [18]Hong Kong is transitioning from the Medical Device Administrative Control System (MDACS), a voluntary listing…
DDReg Knowledge CapsuleeCTD 4.0: Redefining Regulatory Submission Strategy and Digitization
📢 DDReg Knowledge Capsule – Episode [17] The significant global shift toward eCTD 4.0 for regulatory dossier submissions in the pharmaceutical industry. This…
DDReg Knowledge CapsuleThe Essential Role of the EU QPPV in Pharmacovigilance
📢 DDReg Knowledge Capsule – Episode [16] Role of the Qualified Person Responsible for Pharmacovigilance (QPPV) in the European Union (EU). It clarifies that…
DDReg Knowledge CapsuleCombination Products: Global Regulatory Convergence and Complexity
📢 DDReg Knowledge Capsule – Episode [15]The regulatory landscape for combination products in 2025, defining them as items where drugs, devices, or biologics…
DDReg Knowledge CapsuleAI Reshaping Pharmacovigilance Signal Detection and Case Management
📢 DDReg Knowledge Capsule – Episode [14]How Artificial Intelligence (AI) is fundamentally transforming the field of pharmacovigilance (PV), specifically in…
DDReg Knowledge CapsulePharmacovigilance for Cell and Gene Therapies
📢 DDReg Knowledge Capsule – Episode [13]This Podcast explains that because CGTs are transformative but complex, specialised pharmacovigilance (PV) is essential…
DDReg Knowledge CapsuleAI Utility in Regulatory Intelligence: Beyond the Hype
📢 DDReg Knowledge Capsule – Episode [12] Discusses the application of Artificial Intelligence (AI) in Regulatory Intelligence (RI), seeking to differentiate…
DDReg Knowledge CapsulemRNA Technology: Expansion Beyond Vaccines
📢 DDReg Knowledge Capsule – Episode [11]while the COVID-19 pandemic accelerated mRNA visibility, its scope now includes cancer immunotherapies, treatments for…
DDReg Knowledge CapsuleUAE Pharma Gateway: A Guide to UAE Pharmaceutical Registration
The United Arab Emirates is one of the Middle East's fastest-growing pharmaceutical markets, offering a strategic gateway for global manufacturers But entering…
DDReg Knowledge CapsulePharmacovigilance in New Zealand
📢 DDReg Knowledge Capsule – Episode [9]Overview of pharmacovigilance in New Zealand, highlighting the regulatory framework overseen by Medsafe under the…